Literature DB >> 31443391

Structural Insights on Retroviral DNA Integration: Learning from Foamy Viruses.

Ga-Eun Lee1, Eric Mauro2,3, Vincent Parissi2,3, Cha-Gyun Shin1, Paul Lesbats4,5.   

Abstract

Foamy viruses (FV) are retroviruses belonging to the Spumaretrovirinae subfamily. They are non-pathogenic viruses endemic in several mammalian hosts like non-human primates, felines, bovines, and equines. Retroviral DNA integration is a mandatory step and constitutes a prime target for antiretroviral therapy. This activity, conserved among retroviruses and long terminal repeat (LTR) retrotransposons, involves a viral nucleoprotein complex called intasome. In the last decade, a plethora of structural insights on retroviral DNA integration arose from the study of FV. Here, we review the biochemistry and the structural features of the FV integration apparatus and will also discuss the mechanism of action of strand transfer inhibitors.

Entities:  

Keywords:  foamy virus; integrase; integration; retrovirus

Mesh:

Substances:

Year:  2019        PMID: 31443391      PMCID: PMC6784120          DOI: 10.3390/v11090770

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  86 in total

1.  An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.

Authors:  Amy L Harper; Malgorzata Sudol; Michael Katzman
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  A homology model of HIV-1 integrase and analysis of mutations designed to test the model.

Authors:  Barry C Johnson; Mathieu Métifiot; Andrea Ferris; Yves Pommier; Stephen H Hughes
Journal:  J Mol Biol       Date:  2013-03-27       Impact factor: 5.469

3.  Molecular dynamics approaches estimate the binding energy of HIV-1 integrase inhibitors and correlate with in vitro activity.

Authors:  Barry C Johnson; Mathieu Métifiot; Yves Pommier; Stephen H Hughes
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

4.  Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.

Authors:  F Dyda; A B Hickman; T M Jenkins; A Engelman; R Craigie; D R Davies
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

Review 5.  Structure Based Drug Design: Clinically Relevant HIV-1 Integrase Inhibitors.

Authors:  Maninder Kaur; Ravindra K Rawal; Goutam Rath; Amit K Goyal
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

Review 6.  Retroviral intasomes arising.

Authors:  Alan N Engelman; Peter Cherepanov
Journal:  Curr Opin Struct Biol       Date:  2017-04-28       Impact factor: 6.809

Review 7.  Raltegravir: the first HIV integrase inhibitor.

Authors:  Jennifer Cocohoba; Betty J Dong
Journal:  Clin Ther       Date:  2008-10       Impact factor: 3.393

8.  Substrate recognition and motion mode analyses of PFV integrase in complex with viral DNA via coarse-grained models.

Authors:  Jianping Hu; Ming Liu; Dianyong Tang; Shan Chang
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

9.  Cryo-EM reveals a novel octameric integrase structure for betaretroviral intasome function.

Authors:  Allison Ballandras-Colas; Monica Brown; Nicola J Cook; Tamaria G Dewdney; Borries Demeler; Peter Cherepanov; Dmitry Lyumkis; Alan N Engelman
Journal:  Nature       Date:  2016-02-18       Impact factor: 49.962

10.  Comparison of Newly Assembled Full Length HIV-1 Integrase With Prototype Foamy Virus Integrase: Structure-Function Prospective.

Authors:  Mohammad Reza Dayer
Journal:  Jundishapur J Microbiol       Date:  2016-02-15       Impact factor: 0.747

View more
  2 in total

1.  Multiple Infiltration and Cross-Species Transmission of Foamy Viruses across the Paleozoic to the Cenozoic Era.

Authors:  Yicong Chen; Yu-Yi Zhang; Xiaoman Wei; Jie Cui
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

Review 2.  Foamy Viruses, Bet, and APOBEC3 Restriction.

Authors:  Ananda Ayyappan Jaguva Vasudevan; Daniel Becker; Tom Luedde; Holger Gohlke; Carsten Münk
Journal:  Viruses       Date:  2021-03-18       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.